U.S. Health Care REITs Stock News

This article examines whether General Dynamics at US$358.86 is priced for perfection or still offers value, focusing on what the current share price implies. The stock has returned 5.1% over the past week, 3.6% over the past month, 4.5% year to date and 30.6% over the past year, with longer term returns of 77.5% over three years and 112.8% over five years shaping how investors think about risk and reward. Recent news coverage has focused on General Dynamics' position as a major US defense...

Wondering if Electronic Arts at around US$203 per share still offers fair value, or if the recent run has pushed the stock too far. The stock is roughly flat over the past week, up 1.4% over the last month, slightly down 0.7% year to date, yet has delivered 35.9% over 1 year, 59.8% over 3 years and 46.9% over 5 years, which can change how you think about risk and return. Recent coverage has focused on Electronic Arts as a large US gaming company, including ongoing attention on its content...

Wondering whether Ategrity Specialty Insurance Company Holdings at US$21.02 is pricing in its potential, or leaving room on the table for value focused investors. The stock has moved 8.1% over the past week and 8.4% over the past month, while being down 12.4% over the last year, which may have shifted how investors view both its upside and its risks. Recent headlines have focused on Ategrity Specialty Insurance Company Holdings as part of broader interest in specialty insurers, with...

Relay Therapeutics recently gained shareholder approval at its June 9, 2026 annual meeting to amend its certificate of incorporation and raise its authorized common stock capacity from 300,000,000 to 450,000,000 shares. At the same time, research firms highlighted encouraging initial clinical data for zovegalisib in vascular malformations, prompting more optimistic assessments of the drug’s commercial potential. We’ll now examine how the upgraded outlook for zovegalisib’s commercial...

Trane Technologies (NYSE:TT) has appointed Donald E. Simmons as Chief Operating Officer. Simmons has been with the company for 25 years and has held leadership roles across multiple business units. As COO, he will oversee all regional business units and operations with a focus on tighter operational alignment. The appointment is positioned as an important step in advancing the company’s growth strategy. Trane Technologies, traded on the NYSE under the ticker TT, focuses on heating,...

Tripadvisor (NasdaqGS:TRIP) has released its 2026 Travelers' Choice Best of the Best Hotels awards. The rankings highlight hotels in the US, Vietnam, Indonesia, and Ireland based on traveler reviews and experiences. The awards spotlight emerging travel trends and global hospitality quality across several key destinations. Tripadvisor, through its core reviews and travel guidance platform, plays a central role in how travelers research and select hotels worldwide. The 2026 Travelers' Choice...

Investors may wish to note that the Director of Silvaco Group, Inc. , Iliya Pesic, recently netted US$78k from selling...

Shoe Carnival, Inc.'s ( NASDAQ:SCVL ) recent soft profit numbers didn't appear to worry shareholders, as the stock...

Viking Therapeutics (NasdaqCM:VKTX) has appointed Dr. Hubert C. Chen as chief medical officer. Dr. Chen brings extensive experience in drug discovery, clinical development, and regulatory strategy. The appointment expands the company’s senior leadership as its pipeline of metabolic and endocrine therapies progresses. Viking Therapeutics focuses on developing therapies for metabolic and endocrine disorders, areas that continue to attract attention as obesity, liver disease, and related...

Dana stock performance snapshot Dana (DAN) has drawn investor attention after recent trading, with the stock down 15% over the past day and 18% over the past week, extending a month decline of 11%. See our latest analysis for Dana. That sharp 15.1% one day share price decline adds to weaker recent momentum, even though year to date the share price return remains positive and the 1 year total shareholder return of 76.3% is much stronger. If recent volatility has you reassessing opportunities...

In June 2026, Organon reported that the US FDA approved a supplemental Biologics License Application expanding TOFIDENCE, a tocilizumab biosimilar to ACTEMRA, to treat CAR T cell-induced severe cytokine release syndrome and certain hospitalized COVID-19 patients aged 2 years and older. This makes TOFIDENCE the first tocilizumab biosimilar available in the US across a broad range of autoimmune and acute inflammatory indications, potentially reinforcing Organon’s focus on expanding its...

Wondering if Goldman Sachs Group at US$1,035.64 is still offering value after a strong run, or if most of the opportunity is already priced in. The stock is down 5.2% over the past week, up 9.5% over the past month, up 13.3% year to date and up 69.0% over the past year. This naturally raises questions about both growth potential and changing risk perceptions. Recent coverage has focused on how a long stretch of strong returns, including a gain of very large magnitude over three years and...

Pagaya Technologies (NasdaqCM:PGY) is expanding its AI-powered underwriting partnership with Upgrade, Inc. into the Buy Now, Pay Later Flex Pay platform. The move extends Pagaya’s credit decisioning tools from personal loans into point of sale lending, with a focus on travel-related transactions. This development broadens Pagaya’s exposure to the BNPL asset class and introduces new use cases within Upgrade’s ecosystem. Pagaya Technologies runs an AI driven credit analysis and underwriting...

If you are wondering whether Main Street Capital at around US$51.74 is attractively priced or asking too much for its prospects, you are asking the right question for this stock. The share price is down 0.5% over the past week, 2.2% over the past month, and 16.2% year to date, even though the 3 year and 5 year returns sit at 67.3% and 82.6% respectively. Recent attention on Main Street Capital has centered on how its business development model fits into a higher rate backdrop and what that...

In recent days, The Cheesecake Factory’s first-quarter 2026 results showed a 1.6% increase in same-store sales, and JPMorgan shifted its rating on the stock from Underweight to Neutral. This combination of improving same-store performance and a more constructive analyst stance has sharpened attention on the company’s profit margin outlook and overall business momentum. With profit margins now under a brighter spotlight following the strong quarter, we’ll explore how this development...

ADESA, Carvana's wholesale auction platform, has launched ADESA Timed, a new self-service digital auction product. The product expands digital selling tools to a broader group of wholesale auto sellers. This development marks an expansion of Carvana's B2B digital footprint beyond its core consumer facing retail platform. Carvana (NYSE:CVNA) is adding this new capability while its stock trades at $67.82, with a very large 3 year return and a 1 year return of 6.3%. The share price is up 2.5%...

This article examines whether Uranium Energy at US$10.63 still offers value or if the easy gains are behind it, and explores what the current price may be implying about the stock. The share price has been volatile recently, with the stock down 24.8% over the past week and 31.4% over the past month. It remains up 70.6% over the past year and about 3.3x over the past three years. Recent moves in uranium related stocks have kept attention on the sector as investors weigh long term demand for...

If you are wondering whether Dollar General stock offers good value at around US$114.34, the starting point is understanding how its current price lines up against a range of valuation checks. The stock has recently moved sharply, with a gain of 10.5% over the past week and 11.0% over the past month, even though the year to date return is a decline of 16.4% and the 5 year return is a decline of 41.9%. Those mixed returns give important context for today’s price, especially as investors weigh...

GDS Holdings stock snapshot after recent performance shifts GDS Holdings (NasdaqGM:GDS) has drawn fresh attention after a mixed stretch, with the stock up 0.8% on the day but down about 21% over the past month and past 3 months. At a last close of US$33.76 and a market value near US$6.7b, the company continues to focus on developing and operating data centers in China while offering colocation, managed hosting, managed cloud and consulting services. See our latest analysis for GDS...

If you are wondering whether Dave's current share price reflects its fundamentals, this breakdown will help you assess what you are really paying for. Dave's stock recently closed at US$285.43, with returns of 9.1% over the past week, 17.8% over the past month and 30.0% year to date. This naturally raises questions about how much value is already in the price. Over the last year the stock has delivered a 19.8% return, while the 3 year return figure is very large. This puts more attention on...

With the Federal Reserve now signaling that interest rate hikes are on the way, short duration fixed income and money market funds are back in the spotlight as investors weigh higher borrowing costs, slower growth risk, and pressure on stock valuations. This article uses a targeted screener built around that Fed shift to highlight where the news may matter most. You will see three stocks held by investment grade short-term funds that look relatively well positioned for this rate story, why...

Some STERIS plc ( NYSE:STE ) shareholders may be a little concerned to see that the President, Daniel Carestio...

If you are wondering whether Shake Shack's current share price really reflects what the business is worth, the starting point is to look closely at how the market is valuing it today. The stock closed at US$58.33, with a gain of 9.3% over the past week, but it is still down 11.7% over the past month, 30.1% year to date and 54.5% over the past year, which naturally raises questions about both risk and potential recovery. Recent coverage has focused on how a prolonged share price decline...

Investors may be wondering if Xcel Energy at around US$78.27 is offering fair value right now, or if the price is outpacing what the fundamentals might support. The stock is up 0.6% over the last week, slightly down 2.0% over the past month, up 4.8% year to date, and shows returns of 16.9% over 1 year, 33.8% over 3 years, and 33.3% over 5 years. These figures can influence how investors think about both opportunity and risk. Recent headlines around Xcel Energy have focused on its role as a...